Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Study Details
Study Description
Brief Summary
RATIONALE: Giving radiation therapy that uses a 3-dimensional (3-D) image of the tumor to help focus thin beams of radiation directly on the tumor, and giving radiation therapy in higher doses over a shorter period of time, may kill more tumor cells and have fewer side effects. Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. It is not yet known whether radiation therapy is more effective when given alone or together with cetuximab in treating patients with head and neck cancer that has been removed by surgery.
PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared with radiation therapy given together with cetuximab in treating patients who have undergone surgery for locally advanced head and neck cancer.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Detailed Description
OBJECTIVES:
Primary
- Determine whether the addition of cetuximab to postoperative intensity-modulated radiotherapy (IMRT) will improve overall survival (OS) in patients with locally advanced squamous cell carcinoma of the head and neck at intermediate risk following surgery.
Secondary
-
Assess the impact of the addition of cetuximab to postoperative IMRT on disease-free survival (DFS) of these patients.
-
Assess the impact of the addition of cetuximab to postoperative IMRT on acute and late dysphagia, xerostomia, skin toxicity, and other toxicities according to common Toxicity Criteria for Adverse Effects (CTCAE), v. 4 and their relationships with patient-reported outcomes at 3, 12, and 24 months.
-
Analyze tumor for epidermal growth factor receptor (EGFR), specifically the extent of EGFR overexpression by immuno-histochemistry (IHC) and FISH analysis, EGFRvIII expression, as well as the association of these assay data with OS and DFS.
-
Analyze tumor for human papillomavirus (HPV) infection (as defined by in situ hybridization), specifically, within the cohort of patients with oropharynx cancer, to perform an exploratory analysis of the impact of HPV on DFS and OS of this patient subset.
-
Analyze tumor DNA for TP53 mutations as a predictor of response to cetuximab and prognosis.
-
Analyze germline DNA of polymorphic variants in EGFR intron repeats as a predictor of response to cetuximab.
Tertiary
-
Assess the impact of the addition of cetuximab to postoperative IMRT on loco-regional control.
-
Assess the impact of the addition of cetuximab to postoperative IMRT on patient-reported quality of life, swallowing, xerostomia, and skin toxicity based on head and neck specific instruments, including the Performance Status Scale for Head and Neck Cancer (PSS-HN), the Functional Assessment of Cancer Therapy-Head & Neck (FACT-H&N), the University of Michigan Xerostomia-Related Quality of Life Scale (XeQOLS), and the Dermatology Life Quality Index (DLQI).
-
Assess the impact of the addition of cetuximab to postoperative IMRT on cost-utility analysis using the EuroQol (EQ-5D).
-
Evaluate the utility of image-guided radiotherapy (IGRT) as a means of enhancing the efficacy (i.e., loco-regional control) of IMRT while reducing the acute and/or late toxicity (particularly xerostomia) and improving patient-reported outcomes (particularly XeQOLS scores).
-
Retrospectively compare the loco-regional control rate in patients treated with IMRT alone (no IGRT or cetuximab) with similar patients treated with external beam radiotherapy alone in the postoperative clinical trial Radiation Therapy Oncology Group (RTOG)-95 01.
OUTLINE: This is a multicenter study. Patients are stratified according to clinical stage (T2-3 vs T4a), EGFR expression (high [≥ 80% of cells staining positive] vs low [< 80% of cells staining positive] vs not evaluable), primary site of disease (oral cavity vs larynx vs oropharynx p16+ vs oropharynx p16- vs oropharynx, p16 not evaluable), and use of image-guided radiotherapy (yes vs no). Patients are randomized to 1 of 2 treatment arms.
-
Arm I: Patients undergo intensity-modulated radiotherapy (IMRT) once daily 5 days a week for 6 weeks in the absence of disease progression or unacceptable toxicity.
-
Arm II: Patients undergo IMRT as in arm I. Patients also receive cetuximab IV over 1-2 hours once weekly beginning at least 5 days prior to the start of IMRT and continuing for 4 weeks after the completion of IMRT (for a total of 11 doses) in the absence of disease progression or unacceptable toxicity.
Quality of life is assessed at baseline and at 3, 12, and 24 months.
Tissue samples are collected periodically for further laboratory analysis.
After completion of study treatment, patients are followed up at 1 and 3 months, every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Arm I: Intensity-Modulated Radiotherapy Patients undergo intensity-modulated radiotherapy (IMRT) once daily 5 days a week for 6 weeks in the absence of disease progression or unacceptable toxicity. |
Radiation: intensity-modulated radiation therapy
Patients undergo radiotherapy.
|
Experimental: Arm II: IMRT plus cetuximab Patients undergo IMRT as in arm I. Patients also receive cetuximab IV over 1-2 hours once weekly beginning at least 5 days prior to the start of IMRT and continuing for 4 weeks after the completion of IMRT (for a total of 11 doses) in the absence of disease progression or unacceptable toxicity. |
Biological: cetuximab
Given IV
Radiation: intensity-modulated radiation therapy
Patients undergo radiotherapy.
|
Outcome Measures
Primary Outcome Measures
- Overall survival [From randomization to date of death or last follow-up. Analysis occurs after 372 events have been reported.]
Secondary Outcome Measures
- Adverse events (dysphagia, xerostomia, and skin toxicity) according to CTCAE, v. 4 and their relationships with patient-reported outcomes at 3, 12, and 24 months [From start of treatment to 2 years after end of treatment.]
- Other acute adverse events (≤ 90 days from start of radiotherapy [RT]) according to CTCAE, v. 4 [From start of treatment to 90 days.]
- Other late adverse events (> 90 days from start of RT) according to CTCAE, v. 4 [From 90 days after start of treatment to last follow-up.]
- Disease-free survival [From randomization to date of failure (local, regional or distant progression or death) or last follow-up. Analysis occurs at the same time as the primary outcome.]
- Loco-regional control [From randomization to date of failure (local or regional progression or distant progression or death) or last follow-up. Analysis occurs at the same time as the primary outcome.]
- Quality of life as measured by Functional Assessment of Cancer Therapy-Head & Neck (FACT-HN) and EuroQol (EQ-5D) at baseline and at 3, 12, and 24 months [From randomization to 2 years.]
- Xerostomia as measured by University of Michigan Xerostomia-Related Quality of Life Scale (XeQOLS) at baseline and at 3, 12, and 24 months [From randomization to 2 years.]
- Swallowing as measured by the normalcy of diet subscale of the Performance Status Scale for Head and Neck Cancer (PSS-HN) at baseline and at 3, 12, and 24 months [From randomization to 2 years.]
- Skin toxicity as measured by the Dermatology Life Quality Index (DLQI) at baseline and at 3, 12, and 24 months [From randomization to 2 years.]
Eligibility Criteria
Criteria
DISEASE CHARACTERISTICS:
-
Histologically confirmed squamous cell carcinoma (including variants, such as verrucous carcinoma, spindle cell carcinoma, or carcinoma not otherwise specified) of the head and neck, including the following subtypes:
-
Oral cavity
-
Oropharynx
-
Larynx
-
Clinical stage T1, N1-2, M0 OR T2-4a, N0-2, M0 disease based on the following diagnostic workup within the past 8 weeks:
-
General history and physical examination by a Radiation Oncologist and/or Medical Oncologist
-
Chest x-ray or chest CT scan (with or without contrast) or chest CT/PET scan (with or without contrast)
-
Must have undergone gross total resection of the primary tumor with curative intent within the past 7 weeks with surgical pathology demonstrating ≥ 1 of the following criteria for "intermediate" risk of recurrence:
-
Perineural invasion
-
Lymphovascular invasion
-
Single lymph node > 3 cm or ≥ 2 lymph nodes (all < 6 cm) (no extracapsular extension)
-
Close margin(s) of resection, defined as cancer extending to within 5 mm of a surgical margin, and/or an initially focally positive margin that is subsequently superseded by intraoperative negative margins (similarly, patients whose tumors had focally positive margins in the main specimen but negative margins from re-excised samples in the region of the positive margin are eligible)
-
Pathologically confirmed T3 or T4a primary tumor
-
T2 oral cavity cancer with > 5 mm depth of invasion
-
No positive margin(s) (defined as tumor present at the cut or inked edge of the tumor), nodal extracapsular extension, and/or gross residual disease after surgery
PATIENT CHARACTERISTICS:
-
Zubrod performance status 0-1
-
Absolute granulocyte count ≥ 1,500/mm³
-
Platelet count ≥ 100,000/mm³
-
Hemoglobin ≥ 8.0 g/dL (transfusion or other intervention allowed)
-
Total bilirubin < 2 times upper limit of normal (ULN)
-
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) < 3 times ULN
-
Serum creatinine < 2 times ULN OR creatinine clearance ≥ 50 mL/min
-
Not pregnant or nursing
-
Negative pregnancy test
-
Fertile patients must use effective contraception
-
No other invasive malignancy within the past 3 years, except for nonmelanomatous skin cancer or previously treated carcinoma in situ of the breast, oral cavity, or cervix
-
No simultaneous primary or bilateral tumors
-
No severe, active co-morbidity, including any of the following:
-
Unstable angina and/or congestive heart failure requiring hospitalization within the past 6 months
-
Transmural myocardial infarction within the past 6 months
-
Acute bacterial or fungal infection requiring IV antibiotics at the time of study registration
-
Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy
-
Idiopathic pulmonary fibrosis or other severe interstitial lung disease that requires oxygen therapy or is thought to have required oxygen therapy within the past year
-
Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects
-
AIDS based on current Centers for Disease Control (CDC) definition
-
Grade 3-4 electrolyte abnormalities according to CTCAE, v. 4, including any of the following:
-
Serum calcium (ionized or adjusted for albumin) < 7 mg/dL or > 12.5 mg/dL*
-
Glucose < 40 mg/dL or > 250 mg/dL
-
Magnesium < 0.9 mg/dL or > 3 mg/dL*
-
Potassium < 3.0 mmol/L or > 6 mmol/L*
-
Sodium < 130 mmol/L or > 155 mmol/L* NOTE: *Despite intervention to normalize levels.
-
No prior allergic reaction to cetuximab
PRIOR CONCURRENT THERAPY:
-
See Disease Characteristics
-
No prior systemic chemotherapy or anti-epidermal growth factor (EGF) therapy for this cancer
-
Prior chemotherapy or anti-EGF therapy for a different cancer allowed
-
No prior radiotherapy to the region of the study cancer that would result in overlap of radiotherapy fields
-
No concurrent amifostine as a radioprotector
-
No concurrent granulocyte colony-stimulating factor or erythropoietin
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Alabama at Birmingham | Birmingham | Alabama | United States | 35294 |
2 | Arizona Oncology Associates-West Orange Grove | Tucson | Arizona | United States | 85704 |
3 | Sutter Cancer Centers Radiation Oncology Services-Auburn | Auburn | California | United States | 95603 |
4 | Sutter Cancer Centers Radiation Oncology Services-Cameron Park | Cameron Park | California | United States | 95682 |
5 | Mercy San Juan Medical Center | Carmichael | California | United States | 95608 |
6 | City of Hope | Duarte | California | United States | 91010 |
7 | UC San Diego Moores Cancer Center | La Jolla | California | United States | 92093 |
8 | Kaiser Permanente Los Angeles Medical Center | Los Angeles | California | United States | 90027 |
9 | Los Angeles County-USC Medical Center | Los Angeles | California | United States | 90033 |
10 | University of Southern California/Norris Cancer Center | Los Angeles | California | United States | 90033 |
11 | Memorial Medical Center | Modesto | California | United States | 95355 |
12 | Bay Area Tumor Institute CCOP | Oakland | California | United States | 94609 |
13 | Pomona Valley Hospital Medical Center | Pomona | California | United States | 91767 |
14 | Sutter Cancer Centers Radiation Oncology Services-Roseville | Roseville | California | United States | 95661 |
15 | The Permanente Medical Group-Roseville Radiation Oncology | Roseville | California | United States | 95678 |
16 | Sutter General Hospital | Sacramento | California | United States | 95816 |
17 | University of California at Davis Cancer Center | Sacramento | California | United States | 95817 |
18 | Mercy General Hospital Radiation Oncology Center | Sacramento | California | United States | 95819 |
19 | Saint Helena Hospital | Saint Helena | California | United States | 94574 |
20 | UCSF-Mount Zion | San Francisco | California | United States | 94115 |
21 | Kaiser Permanente Medical Center - Santa Clara | Santa Clara | California | United States | 95051 |
22 | Stanford University Hospitals and Clinics | Stanford | California | United States | 94305 |
23 | Sutter Cancer Centers Radiation Oncology Services-Vacaville | Vacaville | California | United States | 95687 |
24 | Rocky Mountain Cancer Centers-Aurora | Aurora | Colorado | United States | 80012 |
25 | University of Colorado Cancer Center - Anschutz Cancer Pavilion | Aurora | Colorado | United States | 80045 |
26 | Penrose-Saint Francis Healthcare | Colorado Springs | Colorado | United States | 80907 |
27 | Porter Adventist Hospital | Denver | Colorado | United States | 80210 |
28 | Swedish Medical Center | Englewood | Colorado | United States | 80113 |
29 | Rocky Mountain Cancer Centers-Littleton | Littleton | Colorado | United States | 80120 |
30 | Saint Vincent's Medical Center | Bridgeport | Connecticut | United States | 06606 |
31 | Yale University | New Haven | Connecticut | United States | 06520 |
32 | William Backus Hospital | Norwich | Connecticut | United States | 06360 |
33 | Christiana Care Health System-Christiana Hospital | Newark | Delaware | United States | 19718 |
34 | University of Miami Sylvester Comprehensive Cancer Center at Deerfield Beach | Deerfield Beach | Florida | United States | 33442 |
35 | Mayo Clinic in Florida | Jacksonville | Florida | United States | 32224-9980 |
36 | University of Miami Miller School of Medicine-Sylvester Cancer Center | Miami | Florida | United States | 33136 |
37 | Baptist Hospital of Miami | Miami | Florida | United States | 33176 |
38 | Florida Hospital | Orlando | Florida | United States | 32803 |
39 | UF Cancer Center at Orlando Health | Orlando | Florida | United States | 32806 |
40 | Emory University/Winship Cancer Institute | Atlanta | Georgia | United States | 30322 |
41 | Atlanta VA Medical Center | Decatur | Georgia | United States | 30033 |
42 | Northeast Georgia Medical Center | Gainesville | Georgia | United States | 30501 |
43 | Memorial Health University Medical Center | Savannah | Georgia | United States | 31403 |
44 | Saint Joseph's-Candler Health System | Savannah | Georgia | United States | 31405 |
45 | Queen's Medical Center | Honolulu | Hawaii | United States | 96813 |
46 | University of Hawaii | Honolulu | Hawaii | United States | 96813 |
47 | The Cancer Center of Hawaii-Liliha | Honolulu | Hawaii | United States | 96817 |
48 | Saint Alphonsus Regional Medical Center | Boise | Idaho | United States | 83706 |
49 | John H Stroger Jr Hospital of Cook County | Chicago | Illinois | United States | 60612-3785 |
50 | University of Illinois | Chicago | Illinois | United States | 60612 |
51 | NorthShore University HealthSystem-Evanston Hospital | Evanston | Illinois | United States | 60201 |
52 | Ingalls Memorial Hospital | Harvey | Illinois | United States | 60426 |
53 | Hines Veterans Administration Hospital | Hines | Illinois | United States | 60141 |
54 | Loyola University Medical Center | Maywood | Illinois | United States | 60153 |
55 | Saint John's Hospital | Springfield | Illinois | United States | 62702 |
56 | Memorial Medical Center | Springfield | Illinois | United States | 62781-0001 |
57 | Carle Cancer Center | Urbana | Illinois | United States | 61801 |
58 | Radiation Oncology Associates PC | Fort Wayne | Indiana | United States | 46804 |
59 | Parkview Hospital Randallia | Fort Wayne | Indiana | United States | 46805 |
60 | IU Health Methodist Hospital | Indianapolis | Indiana | United States | 46202 |
61 | Community Regional Cancer Care-East Radiation Oncology | Indianapolis | Indiana | United States | 46219 |
62 | Community Regional Cancer Care-North | Indianapolis | Indiana | United States | 46256 |
63 | IU Health Ball Memorial Hospital | Muncie | Indiana | United States | 47303 |
64 | McFarland Clinic PC-William R Bliss Cancer Center | Ames | Iowa | United States | 50010 |
65 | Iowa Methodist Medical Center | Des Moines | Iowa | United States | 50309 |
66 | Mercy Medical Center - Des Moines | Des Moines | Iowa | United States | 50314 |
67 | University of Iowa Hospitals and Clinics | Iowa City | Iowa | United States | 52242 |
68 | Siouxland Hematology Oncology Associates | Sioux City | Iowa | United States | 51101 |
69 | University of Kansas Medical Center | Kansas City | Kansas | United States | 66160 |
70 | University of Kentucky | Lexington | Kentucky | United States | 40536 |
71 | The James Graham Brown Cancer Center at University of Louisville | Louisville | Kentucky | United States | 40202 |
72 | Mary Bird Perkins Cancer Center | Baton Rouge | Louisiana | United States | 70809 |
73 | Tulane University Health Sciences Center | New Orleans | Louisiana | United States | 70112 |
74 | Touro Infirmary | New Orleans | Louisiana | United States | 70115 |
75 | Central Maine Medical Center | Lewiston | Maine | United States | 04240 |
76 | University of Maryland/Greenebaum Cancer Center | Baltimore | Maryland | United States | 21201 |
77 | Peninsula Regional Medical Center | Salisbury | Maryland | United States | 21801 |
78 | Tufts Medical Center | Boston | Massachusetts | United States | 02111 |
79 | Boston Medical Center | Boston | Massachusetts | United States | 02118 |
80 | Lahey Hospital and Medical Center | Burlington | Massachusetts | United States | 01805 |
81 | Saint Joseph Mercy Hospital | Ann Arbor | Michigan | United States | 48106-0995 |
82 | University of Michigan | Ann Arbor | Michigan | United States | 48109 |
83 | Oakwood Hospital | Dearborn | Michigan | United States | 48124 |
84 | Wayne State University/Karmanos Cancer Institute | Detroit | Michigan | United States | 48201 |
85 | Henry Ford Hospital | Detroit | Michigan | United States | 48202 |
86 | Saint John Hospital and Medical Center | Detroit | Michigan | United States | 48236 |
87 | West Michigan Cancer Center | Kalamazoo | Michigan | United States | 49007 |
88 | Saint Mary's of Michigan | Saginaw | Michigan | United States | 48601 |
89 | Saint John Macomb-Oakland Hospital | Warren | Michigan | United States | 48093 |
90 | Mercy Hospital | Coon Rapids | Minnesota | United States | 55433 |
91 | Saint Luke's Hospital of Duluth | Duluth | Minnesota | United States | 55805 |
92 | Unity Hospital | Fridley | Minnesota | United States | 55432 |
93 | Minnesota Oncology Hematology PA-Maplewood | Maplewood | Minnesota | United States | 55109 |
94 | Mayo Clinic | Rochester | Minnesota | United States | 55905 |
95 | Regions Hospital | Saint Paul | Minnesota | United States | 55101 |
96 | University of Mississippi Medical Center | Jackson | Mississippi | United States | 39216 |
97 | Singing River Hospital | Pascagoula | Mississippi | United States | 39581 |
98 | Cape Radiation Oncology | Cape Girardeau | Missouri | United States | 63703 |
99 | University of Missouri - Ellis Fischel | Columbia | Missouri | United States | 65212 |
100 | Kansas City Cancer Centers - North | Kansas City | Missouri | United States | 64154 |
101 | Kansas City Cancer Center-Lee's Summit | Lee's Summit | Missouri | United States | 64064 |
102 | Saint Louis University Hospital | Saint Louis | Missouri | United States | 63110 |
103 | Washington University School of Medicine | Saint Louis | Missouri | United States | 63110 |
104 | Siteman Cancer Center-South County | Saint Louis | Missouri | United States | 63129 |
105 | Missouri Baptist Medical Center | Saint Louis | Missouri | United States | 63131 |
106 | Barnes-Jewish West County Hospital | Saint Louis | Missouri | United States | 63141 |
107 | Saint John's Mercy Medical Center | Saint Louis | Missouri | United States | 63141 |
108 | Siteman Cancer Center - Saint Peters | Saint Peters | Missouri | United States | 63376 |
109 | Mercy Hospital Springfield | Springfield | Missouri | United States | 65804 |
110 | CoxHealth South Hospital | Springfield | Missouri | United States | 65807 |
111 | Saint Elizabeth Regional Medical Center | Lincoln | Nebraska | United States | 68510 |
112 | Nebraska Methodist Hospital | Omaha | Nebraska | United States | 68114 |
113 | The Nebraska Medical Center | Omaha | Nebraska | United States | 68198 |
114 | Renown Regional Medical Center | Reno | Nevada | United States | 89502 |
115 | Exeter Hospital | Exeter | New Hampshire | United States | 03833 |
116 | Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | United States | 03756 |
117 | Memorial Sloan Kettering Cancer Center at Basking Ridge | Basking Ridge | New Jersey | United States | 07920 |
118 | Cooper Hospital University Medical Center | Camden | New Jersey | United States | 08103 |
119 | Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County | Mount Holly | New Jersey | United States | 08060 |
120 | Saint Peter's University Hospital | New Brunswick | New Jersey | United States | 08901 |
121 | UMDNJ - New Jersey Medical School | Newark | New Jersey | United States | 07103 |
122 | Sparta Cancer Treatment Center | Sparta | New Jersey | United States | 07871 |
123 | MD Anderson Cancer Center at Cooper-Voorhees | Voorhees | New Jersey | United States | 08043 |
124 | University of New Mexico | Albuquerque | New Mexico | United States | 87106 |
125 | New York Oncology Hematology PC - Albany | Albany | New York | United States | 12206 |
126 | Maimonides Medical Center | Brooklyn | New York | United States | 11219 |
127 | Sands Cancer Center | Canandaigua | New York | United States | 14424 |
128 | Memorial Sloan Kettering Cancer Center Commack | Commack | New York | United States | 11725 |
129 | Beth Israel Medical Center | New York | New York | United States | 10003 |
130 | Memorial Sloan-Kettering Cancer Center | New York | New York | United States | 10065 |
131 | Highland Hospital | Rochester | New York | United States | 14620 |
132 | University Radiation Oncology | Rochester | New York | United States | 14626 |
133 | University of Rochester | Rochester | New York | United States | 14642 |
134 | Memorial Sloan-Kettering Cancer Center Rockville Centre | Rockville Centre | New York | United States | 11570 |
135 | Memorial Sloan-Kettering Cancer Center at Sleepy Hallow | Sleepy Hollow | New York | United States | 10591 |
136 | Mission Hospital-Memorial Campus | Asheville | North Carolina | United States | 28801 |
137 | University of North Carolina | Chapel Hill | North Carolina | United States | 27599 |
138 | Wayne Radiation Oncology | Goldsboro | North Carolina | United States | 27534 |
139 | Kinston Medical Specialists PA | Kinston | North Carolina | United States | 28501 |
140 | Cancer Centers of North Carolina | Raleigh | North Carolina | United States | 27607 |
141 | Wake Forest University Health Sciences | Winston-Salem | North Carolina | United States | 27157 |
142 | Roger Maris Cancer Center | Fargo | North Dakota | United States | 58122 |
143 | Summa Akron City Hospital/Cooper Cancer Center | Akron | Ohio | United States | 44304 |
144 | Akron General Medical Center | Akron | Ohio | United States | 44307 |
145 | Summa Barberton Hospital | Barberton | Ohio | United States | 44203 |
146 | Mercy Medical Center | Canton | Ohio | United States | 44708 |
147 | Geaugra Hospital | Chardon | Ohio | United States | 44024 |
148 | University of Cincinnati | Cincinnati | Ohio | United States | 45267 |
149 | Case Western Reserve University | Cleveland | Ohio | United States | 44106 |
150 | Cleveland Clinic Cancer Center/Fairview Hospital | Cleveland | Ohio | United States | 44111 |
151 | Cleveland Clinic Foundation | Cleveland | Ohio | United States | 44195 |
152 | Ohio State University Medical Center | Columbus | Ohio | United States | 43210 |
153 | Mercy Cancer Center-Elyria | Elyria | Ohio | United States | 44035 |
154 | Cleveland Clinic Cancer Center Independence | Independence | Ohio | United States | 44131 |
155 | Hillcrest Hospital Cancer Center | Mayfield Heights | Ohio | United States | 44124 |
156 | Summa Health Center at Lake Medina | Medina | Ohio | United States | 44256 |
157 | Lake University Ireland Cancer Center | Mentor | Ohio | United States | 44060 |
158 | Southwest General Health Center Ireland Cancer Center | Middleburg Heights | Ohio | United States | 44130 |
159 | UHHS-Chagrin Highlands Medical Center | Orange Village | Ohio | United States | 44122 |
160 | Saint Charles Hospital | Oregon | Ohio | United States | 43616 |
161 | Robinson Radiation Oncology | Ravenna | Ohio | United States | 44266 |
162 | North Coast Cancer Care | Sandusky | Ohio | United States | 44870 |
163 | Cleveland Clinic Cancer Center-Strongsville | Strongsville | Ohio | United States | 44136 |
164 | Flower Hospital | Sylvania | Ohio | United States | 43560 |
165 | University Pointe | West Chester | Ohio | United States | 45069 |
166 | UHHS-Westlake Medical Center | Westlake | Ohio | United States | 44145 |
167 | Cleveland Clinic Wooster Specialty Center | Wooster | Ohio | United States | 44691 |
168 | University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | United States | 73104 |
169 | Clackamas Radiation Oncology Center | Clackamas | Oregon | United States | 97015 |
170 | Willamette Valley Cancer Center | Eugene | Oregon | United States | 97401 |
171 | Providence Portland Medical Center | Portland | Oregon | United States | 97213 |
172 | Western Oncology Research Consortium | Portland | Oregon | United States | 97213 |
173 | Providence Saint Vincent Medical Center | Portland | Oregon | United States | 97225 |
174 | Oregon Health and Science University | Portland | Oregon | United States | 97239 |
175 | Portland Veterans Administration Medical Center | Portland | Oregon | United States | 97239 |
176 | Salem Hospital | Salem | Oregon | United States | 97301 |
177 | Lehigh Valley Hospital | Allentown | Pennsylvania | United States | 18105 |
178 | Geisinger Medical Center | Danville | Pennsylvania | United States | 17822-2001 |
179 | Northeast Radiation Oncology Center | Dunmore | Pennsylvania | United States | 18512 |
180 | Pocono Medical Center | East Stroudsburg | Pennsylvania | United States | 18301 |
181 | Adams Cancer Center | Gettysburg | Pennsylvania | United States | 17325 |
182 | Cherry Tree Cancer Center | Hanover | Pennsylvania | United States | 17331 |
183 | Saint Mary Medical and Regional Cancer Center | Langhorne | Pennsylvania | United States | 19047 |
184 | University of Pennsylvania/Abramson Cancer Center | Philadelphia | Pennsylvania | United States | 19104 |
185 | Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | United States | 19107 |
186 | Fox Chase Cancer Center | Philadelphia | Pennsylvania | United States | 19111 |
187 | Albert Einstein Medical Center | Philadelphia | Pennsylvania | United States | 19141 |
188 | Reading Hospital | West Reading | Pennsylvania | United States | 19611 |
189 | WellSpan Health-York Hospital | York | Pennsylvania | United States | 17405 |
190 | AnMed Health Cancer Center | Anderson | South Carolina | United States | 29621 |
191 | Medical University of South Carolina | Charleston | South Carolina | United States | 29425 |
192 | Greenville Health System Cancer Institute-Faris | Greenville | South Carolina | United States | 29605 |
193 | Greenville Health System Cancer Institute/Greenville CCOP | Greenville | South Carolina | United States | 29615 |
194 | Gibbs Cancer Center-Pelham | Greer | South Carolina | United States | 29651 |
195 | Spartanburg Regional Medical Center | Spartanburg | South Carolina | United States | 29303 |
196 | Greenville Health System Cancer Institute-Spartanburg | Spartanburg | South Carolina | United States | 29307 |
197 | Rapid City Regional Hospital | Rapid City | South Dakota | United States | 57701 |
198 | Sanford Cancer Center-Oncology Clinic | Sioux Falls | South Dakota | United States | 57104 |
199 | Wellmont Holston Valley Hospital and Medical Center | Kingsport | Tennessee | United States | 37660 |
200 | Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | United States | 37232 |
201 | Texas Oncology-Austin Midtown | Austin | Texas | United States | 78705 |
202 | Texas Oncology - Central Austin Cancer Center | Austin | Texas | United States | 78731 |
203 | Texas Oncology - South Austin Cancer Center | Austin | Texas | United States | 78745 |
204 | Texas Oncology PA - Bedford | Bedford | Texas | United States | 76022 |
205 | University of Texas Southwestern Medical Center | Dallas | Texas | United States | 75390 |
206 | Texas Oncology-Denton South | Denton | Texas | United States | 76210 |
207 | The Klabzuba Cancer Center | Fort Worth | Texas | United States | 76104 |
208 | Memorial Hermann Memorial City Medical Center | Houston | Texas | United States | 77024 |
209 | Ben Taub General Hospital | Houston | Texas | United States | 77030 |
210 | M D Anderson Cancer Center | Houston | Texas | United States | 77030 |
211 | Texas Oncology-Seton Williamson | Round Rock | Texas | United States | 78665 |
212 | Texas Oncology - Round Rock Cancer Center | Round Rock | Texas | United States | 78681 |
213 | Cancer Care Centers of South Texas- Northeast | San Antonio | Texas | United States | 78217 |
214 | University of Texas Health Science Center at San Antonio | San Antonio | Texas | United States | 78229 |
215 | Texas Cancer Center-Sherman | Sherman | Texas | United States | 75090 |
216 | Texas Oncology Cancer Center Sugar Land | Sugar Land | Texas | United States | 77479 |
217 | Texas Oncology-Wichita Falls Texoma Cancer Center | Wichita Falls | Texas | United States | 76310 |
218 | Intermountain Medical Center | Murray | Utah | United States | 84157 |
219 | Dixie Medical Center Regional Cancer Center | Saint George | Utah | United States | 84770 |
220 | Utah Cancer Specialists-Salt Lake City | Salt Lake City | Utah | United States | 84106 |
221 | Huntsman Cancer Institute/University of Utah | Salt Lake City | Utah | United States | 84112 |
222 | LDS Hospital | Salt Lake City | Utah | United States | 84143 |
223 | University of Virginia | Charlottesville | Virginia | United States | 22908 |
224 | Sentara Cancer Institute at Sentara CarePlex Hospital | Hampton | Virginia | United States | 23666 |
225 | Sentara Hospitals | Norfolk | Virginia | United States | 23507 |
226 | Hunter Holmes McGuire Veterans Administration Medical Center | Richmond | Virginia | United States | 23249 |
227 | Virginia Commonwealth University | Richmond | Virginia | United States | 23298 |
228 | Sentara Virginia Beach General Hospital | Virginia Beach | Virginia | United States | 23454 |
229 | Harrison Medical Center | Bremerton | Washington | United States | 98310 |
230 | Tri-Cities Cancer Center | Kennewick | Washington | United States | 99336 |
231 | Skagit Valley Hospital | Mount Vernon | Washington | United States | 98274 |
232 | University of Washington Medical Center | Seattle | Washington | United States | 98195 |
233 | Cancer Care Northwest - Spokane South | Spokane | Washington | United States | 99202 |
234 | Cancer Care Northwest-North Spokane | Spokane | Washington | United States | 99218 |
235 | Northwest CCOP | Tacoma | Washington | United States | 98405 |
236 | PeaceHealth Southwest Medical Center | Vancouver | Washington | United States | 98664 |
237 | Compass Oncology Vancouver | Vancouver | Washington | United States | 98684 |
238 | Wenatchee Valley Medical Center | Wenatchee | Washington | United States | 98801 |
239 | West Virginia University Healthcare | Morgantown | West Virginia | United States | 26506 |
240 | Wheeling Hospital | Wheeling | West Virginia | United States | 26003 |
241 | Langlade Hospital and Cancer Center | Antigo | Wisconsin | United States | 54409 |
242 | Fox Valley Hematology and Oncology | Appleton | Wisconsin | United States | 54911-3496 |
243 | Saint Vincent Hospital | Green Bay | Wisconsin | United States | 54301 |
244 | Gundersen Lutheran | La Crosse | Wisconsin | United States | 54601 |
245 | University of Wisconsin Hospital and Clinics | Madison | Wisconsin | United States | 53792 |
246 | Bay Area Medical Center | Marinette | Wisconsin | United States | 54143 |
247 | Froedtert and the Medical College of Wisconsin | Milwaukee | Wisconsin | United States | 53226 |
248 | Clement J. Zablocki VA Medical Center | Milwaukee | Wisconsin | United States | 53295 |
249 | Door County Cancer Center | Sturgeon Bay | Wisconsin | United States | 54235-1495 |
250 | Aspirus Regional Cancer Center | Wausau | Wisconsin | United States | 54401 |
251 | Cross Cancer Institute | Edmonton | Alberta | Canada | T6G 1Z2 |
252 | CancerCare Manitoba | Winnipeg | Manitoba | Canada | R3E 0V9 |
253 | Doctor H. Bliss Murphy Cancer Centre | St. John's | Newfoundland and Labrador | Canada | A1B 3V6 |
254 | London Regional Cancer Program | London | Ontario | Canada | N6A 4L6 |
255 | Ottawa Health Research Institute-General Division | Ottawa | Ontario | Canada | K1H 1C4 |
256 | Health Sciences North | Sudbury | Ontario | Canada | P3E 5J1 |
257 | University Health Network-Princess Margaret Hospital | Toronto | Ontario | Canada | M5G 2M9 |
258 | CHUM - Hopital Notre-Dame | Montreal | Quebec | Canada | H2L 4M1 |
259 | McGill University Department of Oncology | Montreal | Quebec | Canada | H2W 1S6 |
260 | CHUQ - Pavilion Hotel-Dieu de Quebec | Quebec City | Quebec | Canada | G1R 2J6 |
261 | Centre Hospitalier Universitaire de Sherbrooke-Fleurimont | Sherbrooke | Quebec | Canada | J1H 5N4 |
262 | Allan Blair Cancer Centre | Regina | Saskatchewan | Canada | S4T 7T1 |
263 | Chinese University of Hong Kong-Prince of Wales Hospital | Shatin | Hong Kong | China | OX1 3UJ |
264 | King Faisal Specialist Hospital and Research Centre | Riyadh | Saudi Arabia | 11211 |
Sponsors and Collaborators
- Radiation Therapy Oncology Group
- National Cancer Institute (NCI)
- NRG Oncology
Investigators
- Study Chair: Mitchell Machtay, MD, University Hospitals Seidman Cancer Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RTOG 0920
- CDR0000651536
- NCI-2011-00878
- NCT01311063